Long-term use of antiepileptic drug Vimpat® (lacosamide) effectively reduced partial-onset seizure frequency and improved health-related quality of life
Epratuzumab phase IIb data presented at ACR show pipeline drug had positive effect in patients suffering from moderate to severe systemic lupus erythematosus
New Cimzia (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations with Active Rheumatoid Arthritis (RA)
